Amy Suzon Chappell

CIK: 0002090156

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIVI

BIOVIE INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

BIVI
BIOVIE INC.
Aug 28, 2026
Purchase(P)
Direct
727 shares at avg. $2.16$2K
BIVI
BIOVIE INC.
Jan 5, 2026
Award(A)
Stock Option (right to buy)
Direct
57.5K shares-

		Type	Shares	Price		Ownership
Aug 28, 2026	BIVI BIOVIE INC.	Purchase(P)	727	$2.16	$1,570	Direct
Jan 5, 2026	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	57,500	-	-	Direct

1-2 of 2 transactions

About Chappell Amy Suzon

Chappell Amy Suzon (SEC CIK 0002090156) files insider reports with the SEC as Director of BIOVIE INC. (BIVI).

Signal8 holds 3 ownership filings by Chappell Amy Suzon (1 Form 3, 2 Form 4), filed between Oct 27, 2025 and Aug 28, 2026. Those filings report 2 transactions, from Jan 5, 2026 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chappell Amy Suzon's filings is in CARSON CITY, NV.

Recent filings by Chappell Amy Suzon

Aug 28, 2026: Open-market purchase of BIVI shares (Form 4, code P).
Jan 5, 2026: Grant or award of BIVI derivative securities (Form 4, code A).

Other insiders filing for BIOVIE INC. (BIVI)

Palumbo Joseph M, Chief Medical Officer
KIM JOANNE WENDY, Chief Financial Officer
DO CUONG V, President & CEO
ROGICH SIGMUND, Director
Sherman Michael Edward, Director
Farag Kameel D., Director

How to read Form 4 transaction codes